1. Antroposophic Medicine: effectiveness,utility, costs, safety
This Health Technology Assessment (HTA) report ( was commissioned by the Swiss Federal Social Insurance Office and produced as part of the national Complementary Medicine Evaluation Programme (PEK). The presented review is an update of this HTA-report, providing an overview of the available scientific literature on the effectiveness, utility, costs and safety of anthroposophic medicine.
Kiene GS, Kienle H, Albonico HU: Anthroposophic Medicine: effectiveness, utility,costs, safety. Schattauer, Stuttgart, 2006

2. Effectiveness of AM in clinical studies
Domains of clinical studies
System evaluation AM, includidng system comparisons (various diseases)
Pain conditions and wound care
Non-pharmacological treatments of various diseases
Anthroposophic mistletoe therapy of cancer
Further clinical studies
Chronic hepatitis C and hepatitis B
Acute infections of the upper respiratory tract, ears, eyes and gastrointestinal tract
Obstetrics and gynecology
Psychiatry, neurology
Thyroid disease
Cardiovascular disease
Astma, obstructive pulmonary disease, sarkoidosis
Ulcerative colitis,hay fever and others
Kiene GS, Kienle H, Albonico HU: Anthroposophic Medicine: effectiveness, utility,costs, safety. Schattauer, Stuttgart, 2006

3. Types of study designs Clinical Trials N=195
Prospective Comparative Trials N=40
RCT:s
N=18
RCT:s blinded
N=5
RCT:s not blinded
N=13
Matched Pair Design
N=4
Blinded
N=3
Not blinded
N=1
Retrospective
Comparative Trials N=45
Cohort Studies (Cross over, Pre-post Desigs)
N=110
Prospective
N=62
N=43
Other
Types of study designs
Kiene GS, Kienle H, Albonico HU: Anthroposophic Medicine: effectiveness, utility,costs, safety. Schattauer, Stuttgart, 2006

4. Kiene GS, Kienle H, Albonico HU: Anthroposophic Medicine: effectiveness, utility,costs, safety. Schattauer, Stuttgart, 2006